Home » Topics » BioWorld Science

BioWorld Science
RSS

AMR Centre patents new antibacterials

Dec. 10, 2019

With reduced toxicity, can HSCT make it to Hall of Fame?

Dec. 10, 2019

First-in-human data for novel oral multikinase inhibitor SKLB-1028 in R/R AML

Dec. 10, 2019

Quantitative and inducible modulation of the circadian clock with light using photocaged longdayisin

Dec. 10, 2019

CD3/CD7-IT causes clinical remission and rapid immune reconstitution in SR-aGvHD: phase I/II results

Dec. 10, 2019

Innovent begins phase I study in China with anti-LAG-3 antibody IBI-110

Dec. 10, 2019

First preclinical data in DLBCL for BCMA-targeting 2 + 1 T-cell engager CC-93269

Dec. 10, 2019

DR-10601 shows promise for the treatment of type 2 diabetes and obesity in preclinical models

Dec. 10, 2019

Discovery of novel inhaled JAK inhibitor for the treatment of respiratory diseases

Dec. 10, 2019

First patient dosed in phase I study of BJ-001 in advanced or metastatic solid tumors

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...